Predicting coronary heart disease in renal transplant recipients: a prospective study

Didier Ducloux1, Amir Kazory, Jean-Marc Chalopin

  • 1Department of Nephrology and Renal Transplantation, Saint-Jacques Hospital, University of Franche-Comté, Besançon, France. dducloux@chu-besancon.fr

Kidney International
|June 18, 2004
PubMed

Insights

Cardiovascular risk calculators need validation in kidney transplant patients. Nontraditional factors like C-reactive protein and hyperhomocysteinemia increase ischemic heart disease risk in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Cardiovascular risk calculators lack validation in renal transplant recipients.
  • Ischemic heart disease is a significant concern in this patient group.
  • Assessing traditional and nontraditional risk factors is crucial.

Purpose of the Study:

  • Determine ischemic heart disease incidence and risk factors in renal transplant recipients.
  • Evaluate the Framingham Heart Study risk calculator's relevance in this population.

Main Methods:

  • Prospective study of 344 renal transplant recipients without prior vascular disease.
  • Coronary events tracked and analyzed against cardiovascular risk factors.
  • Framingham Heart Study formula used to assess coronary event risk.

Main Results:

  • Follow-up averaged 72 months; 7.8% experienced coronary events.
  • C-reactive protein and hyperhomocysteinemia identified as independent risk factors.
  • Framingham Heart Study model did not accurately predict overall risk.

Conclusions:

  • Nontraditional factors significantly increase ischemic heart disease risk in transplant patients.
  • Preventive care must address these nontraditional factors to reduce absolute risk.
  • Framingham score underestimates risk in high-risk transplant patients but is accurate for low-risk individuals.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...